Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Teleflex handed class I notice over IV recall

This article was originally published in Clinica

Executive Summary

Teleflex’s recall of its custom intravenous (IV) administration products has been given a class I notification by the FDA – the most serious type of recall notice. The faulty products include IV tubing sets and accessories manufactured by the firm’s Arrow International subsidiary from 2000 through 2009 and distributed prior to 19 February 2010. Teleflex (Limerick, Pennsylvania) discovered pin holes or punctures in the products’ packaging that could cause “blood-borne or other types of infections, which could result in serious injury or death”. The tubing sets are used to transfer fluids from a container to a patient’s blood vessel system.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT077179

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel